Immunity, inflammation and disease

Top Research Topics at Immunity, inflammation and disease?

Immunity, inflammation and disease focuses on Immunology, Immune system, Internal medicine, Inflammation and T cell. It primarily discusses Immunology topics, particularly Cytokine, Antigen, Antibody, Immunoglobulin E and Immunity. The studies tackled, which mainly focus on Cytokine, apply to Chemokine as well.

The Immune system study tackling the subject of Immunotherapy is the focus of it. The work on Internal medicine tackled in it brings together disciplines like Gastroenterology and Endocrinology. It focuses on Inflammation as well as the interrelated topic of Innate immune system.

Immunity, inflammation and disease focuses on T cell but the discussions also offer insight into other areas such as Cytotoxic T cell, CD8 and Cell biology. While work presented in it provided substantial information on Asthma, it also covered topics in Pediatrics and Allergy. It focuses on Allergy research which is adjacent to topics in Sensitization.

• Immunology (41.45%)
• Immune system (22.33%)
• Internal medicine (21.33%)

What are the most cited papers published in the journal?

• Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps. (69 citations)
• Myeloid suppressor cells require membrane TNFR2 expression for suppressive activity (56 citations)
• Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients. (55 citations)

Research areas of the most cited articles at Immunity, inflammation and disease:

The journal articles focus on Immunology, Immune system, Internal medicine, Asthma and Antibody. The journal articles explore topics in Immunology which can be helpful for research in disciplines like Gene and Disease. The journal papers explore issues in Immune system which can be linked to other research areas like Bacterial artificial chromosome and Green fluorescent protein.

What topics the last edition of the journal is best known for?

• Internal medicine
• Gene
• Immune system

The previous edition focused in particular on these issues:

The discussions in Immunity, inflammation and disease mainly cover the fields of Internal medicine, Immunology, Immune system, Inflammation and Cancer research. Immunity, inflammation and disease holds forums on Internal medicine that merges themes from other disciplines such as Gastroenterology and Oncology. Immunity, inflammation and disease tackles studies in Peripheral blood mononuclear cell and the interrelated subject of Receptor to gain insights into Immunology.

Immune system research featured in Immunity, inflammation and disease incorporates concerns from various other topics such as Gene and Cytokine. The presented research on Inflammation deals specifically with Downregulation and upregulation but it also addresses topics in Cell biology. The journal explores issues in Cancer research which can be linked to other research areas like Proinflammatory cytokine, Apoptosis and Flow cytometry.

The most cited articles from the last journal are:

• Does COVID-19 contribute to development of neurological disease? (8 citations)
• Evidence and implications of pre-existing humoral cross-reactive immunity to SARS-CoV-2. (8 citations)
• Age-related differences in the immune response could contribute to determine the spectrum of severity of COVID-19. (7 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Immunity, inflammation and disease (based on the number of publications) are:

• Yosuke Kanno (3 papers) absent at the last edition,
• Jennifer Jaufmann (3 papers) published 2 papers at the last edition, 1 more than at the previous edition,
• Fanqin Bu (3 papers) published 2 papers at the last edition, 1 more than at the previous edition,
• Shiro Murata (3 papers) published 1 paper at the last edition,
• Tomohiro Okagawa (3 papers) published 1 paper at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Immunity, inflammation and disease (based on the number of publications) are:

• Nanchang University (10 papers) published 9 papers at the last edition, 8 more than at the previous edition,
• Sun Yat-sen University (10 papers) published 8 papers at the last edition, 6 more than at the previous edition,
• Boston Children's Hospital (10 papers) published 3 papers at the last edition, 1 more than at the previous edition,
• National Institutes of Health (9 papers) published 1 paper at the last edition, 1 less than at the previous edition,
• University of Manchester (7 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 13.64% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 17.11% were posted by at least one author from the top 10 institutions publishing in the journal. Another 11.84% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 19.08% of all publications and 51.97% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.